Octave Bioscience, Inc., a commercial-stage precision neurology company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases such as Parkinson’s disease, ...
Wainua’s ATTR-CM failure is a setback for the AstraZeneca program, but it doesn’t kill the underlying platform value: Ionis ...
Doha: The Primary Health Care Corporation (PHCC) has affirmed that its commitment to investing in national specialized workforces is the core pillar of advancing health and social services and the ...
Asthma is the most common chronic airway disease worldwide, imposing substantial clinical, societal, and economic burden.
The CIA officer Ray Cline, who was the agency’s chief analyst during the Cuban missile crisis, once observed that when it comes to intelligence analysis, “objectivity is the only virtue that really ...
Highlights:NQ diamond drill rig from Proterra Drilling has been mobilized to site, with drilling now underwayApproximately four (4) drillholes totaling ~1,200 metres plannedTwo deeper drillholes desig ...
Fredonia Mining Inc. (“Fredonia” or the “Company”) (TSXV: FRED) is pleased to provide an update on the continued advancement of its flagship El Dorado Monserrat (“EDM”) Project in Santa Cruz Province, ...
The United States is set to supply GE F110 engines for Turkey’s indigenous KAAN stealth fighter, marking a major boost for Ankara’s defence programme. Here’s how the deal compares with India’s AMCA ...
Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”) is pleased to announce that it will have completed the Phase 2 earn-in requirements (“Phase 2”) under its Option ...
A federal judge in South Carolina ruled that the Trump administration’s decision to terminate an environmental justice grant program was “arbitrary and capricious and unlawful.” The lead plaintiff in ...
Many travelers dream of one day living abroad, but a growing number of US citizens are making that fantasy a reality. Demand for additional citizenship, residency, and investment opportunities ...
US FDA approves Keytruda and Keytruda Qlex, each with Trodelvy as first-line treatment of PD-L1+ (CPS =10) advanced TNBC: Rahway, New Jersey Friday, June 26, 2026, 09:00 Hrs [IST] ...